Breast Cancer Liquid Biopsy Market - 2024-2031

July 2026 | 53 pages | ID: B5F6E098BD32EN
DataM Intelligence

Abstracts

Breast Cancer Liquid Biopsy Marketis is growing with a CAGR of 23.20% during the forecast period 2026-2035.

The Breast Cancer Liquid Biopsy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Breast Cancer Liquid Biopsy Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type

• Reagents and Kits*
• Instruments

By Circulating Biomarkers

• Circulating Tumor Cells (CTCs)*
• Circulating Cell-free DNA (cfDNA)
• Extracellular Vesicles
• Others

By Application

• Early Screening*
• Treatment Selection

By End-User

• Hospitals*
• Diagnostic Centers
• Research and Educational Institutions
• Others

Regional Analysis for Breast Cancer Liquid Biopsy Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Breast Cancer Liquid Biopsy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Product Type
3.2. Snippet by Circulating Biomarkers
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing Prevalence of Breast Cancer
    4.1.1.2. Increasing Awareness Among People
    4.1.1.3. Technological Advancements
  4.1.2. Restraints
    4.1.2.1. High Costs Associated with Liquid Biopsy
    4.1.2.2. Shortage of Skilled Professionals
    4.1.2.3. Stringent Regulatory Requirements
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. BY PRODUCT TYPE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  6.1.2. Market Attractiveness Index, By Product Type
6.2. Reagents and Kits*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Instruments

7. BY CIRCULATING BIOMARKERS

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarkers
  7.1.2. Market Attractiveness Index, By Circulating Biomarkers
7.2. Circulating Tumor Cells (CTCs)*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Circulating Cell-free DNA (cfDNA)
7.4. Extracellular Vesicles
7.5. Others

8. BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index, By Application
8.2. Early Screening*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Treatment Selection

9. BY END-USER

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic Centers
9.4. Research and Educational Institutions
9.5. Others

10. BY REGION

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  10.1.2. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarkers
  10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.2.7.1. The U.S.
    10.2.7.2. Canada
    10.2.7.3. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarkers
  10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.3.7.1. Germany
    10.3.7.2. UK
    10.3.7.3. France
    10.3.7.4. Italy
    10.3.7.5. Spain
    10.3.7.6. Rest of Europe
10.4. South America
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarkers
  10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.4.7.1. Brazil
    10.4.7.2. Argentina
    10.4.7.3. Rest of South America
10.5. Asia-Pacific
  10.5.1. Introduction
  10.5.2. Key Region-Specific Dynamics
  10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulatory Biomarkers
  10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.5.7.1. China
    10.5.7.2. India
    10.5.7.3. Japan
    10.5.7.4. South Korea
    10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
  10.6.1. Introduction
  10.6.2. Key Region-Specific Dynamics
  10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulatory Biomarkers
  10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. COMPETITIVE LANDSCAPE

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. COMPANY PROFILES

12.1. F. Hoffmann-La Roche Ltd. *
  12.1.1. Company Overview
  12.1.2. Product Portfolio and Description
  12.1.3. Financial Overview
  12.1.4. Key Developments
12.2. Thermo Fisher Scientific Inc.
12.3. Abbott
12.4. Agilent Technologies Inc.
12.5. Merck KGaA
12.6. Cell Signaling Technology Inc.
12.7. Medtronic
12.8. Bio-Rad Laboratories Inc.
12.9. ExoDx
12.10. Biocept Inc. (*LIST NOT EXHAUSTIVE)

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us